These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32876856)

  • 21. Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
    Inal A; Kaplan MA; Kucukoner M; Urakcı Z; Kılınc F; Isıkdogan A
    Rev Port Pneumol; 2014; 20(2):62-8. PubMed ID: 24210228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Survival benefit of an herbal formula for invigorating spleen for elderly patients with gastric cancer].
    Zhao AG; Cao W; Xu Y; Zhao G; Liu BY; Cai Y; Yang JZ; Gu Y; Yuan W; Zhu YJ; Han YY; Yang JY
    Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):224-30. PubMed ID: 20226143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience.
    Machtay M; Seiferheld W; Komaki R; Cox JD; Sause WT; Byhardt RW
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):847-53. PubMed ID: 10386642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multivariate survival analysis of patients with stage I NSCLC].
    Pei J; Han B; Zhang J; Gu A
    Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):926-32. PubMed ID: 22152692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Classification and regression tree analysis of clinical patterns that predict survival in 127 Chinese patients with advanced non-small cell lung cancer treated by gefitinib who failed to previous chemotherapy].
    Wang Z; Guo J; Wang Y; Liu Y; Yang J
    Zhongguo Fei Ai Za Zhi; 2011 Sep; 14(9):699-703. PubMed ID: 21924034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic analysis of advanced non small cell lung cancer treated by sequential chemo-radiation therapy combined with traditional Chinese medicine: a report of 54 cases].
    Han MQ; Su JM; Huang HY; Long WH; Qin LP; Qin P; Liu W; Sheng ZY
    Zhong Xi Yi Jie He Xue Bao; 2003 Sep; 1(3):195-8. PubMed ID: 15339560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive geriatric assessment and traditional Chinese medicine intervention benefit symptom control in elderly patients with advanced non-small cell lung cancer.
    Xue D; Han S; Jiang S; Sun H; Chen Y; Li Y; Wang W; Feng Y; Wang K; Li P
    Med Oncol; 2015 Apr; 32(4):114. PubMed ID: 25772512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective study on the effect of Chinese patent medicine combined with conventional treatment on the survival outcomes of 313 patients with stage II-III NSCLC.
    Jia K; Zhang C; Li F; He B; Xie S; Du J; Feng G
    Aging (Albany NY); 2024 Mar; 16(7):6212-6228. PubMed ID: 38555532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients.
    Mo H; Hao X; Liu Y; Wang L; Hu X; Xu J; Yang S; Xing P; Shi Y; Jia B; Wang Y; Li J; Wang H; Wang Z; Sun Y; Shi Y
    Cancer Med; 2016 Jun; 5(6):1116-24. PubMed ID: 26993156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
    Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers].
    Zhang ZR; Mao YS; Gao SG; Mu JW; Xue Q; Wang DL; Gao YS; Zhao J; He J
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):460-5. PubMed ID: 27346405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
    Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
    JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study.
    Wang L; Jia K; Li F; Zhang C; Feng G; Du J
    Front Pharmacol; 2021; 12():719802. PubMed ID: 34539404
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of Chinese medicine comprehensive regimen as the maintenance therapy on time to progression and quality of life of patients with advanced non-small-cell lung cancer].
    Jiang Y; Liu LS; Li CJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1311-6. PubMed ID: 22097195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognosis of locally advanced non small cell lung cancer treated with three dimentional conformal radiotherapy].
    Zhu XZ; Wang LH; Ou GF; Zhou ZM; Chen DF; Xiao ZF; Feng QF; Zhang HX; Wang M; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):748-53. PubMed ID: 18396686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic chemotherapy in advanced non-small cell lung cancer with poor performance status: A retrospective analysis from routine clinical practice.
    Kancharla H; Gundu N; Pathak N; Vandidassane I; Khurana S; Pushpam D; Jain D; Kumar S; Pathy S; Mohan A; Malik PS
    Curr Probl Cancer; 2020 Jun; 44(3):100550. PubMed ID: 31987521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.
    Buti S; Bordi P; Tiseo M; Bria E; Sperduti I; Di Maio M; Panni S; Novello S; Rapetti SG; Pilotto S; Genestreti G; Rossi A; Pezzuolo D; Camisa R; Tortora G; Ardizzoni A
    Lung Cancer; 2015 Jun; 88(3):319-24. PubMed ID: 25870156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.